DMKJ

David M. Knott Jr Portfolio holdings

AUM $221M
This Quarter Return
-3.69%
1 Year Return
+22.52%
3 Year Return
+148.91%
5 Year Return
–
10 Year Return
–
AUM
$314M
AUM Growth
+$314M
Cap. Flow
+$34.7M
Cap. Flow %
11.04%
Top 10 Hldgs %
50.17%
Holding
161
New
29
Increased
30
Reduced
25
Closed
21

Top Buys

1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$6.43M
2
CLMT icon
Calumet Specialty Products
CLMT
$6M
3
LGND icon
Ligand Pharmaceuticals
LGND
$4.5M
4
JNJ icon
Johnson & Johnson
JNJ
$3.69M
5
DCGO icon
DocGo
DCGO
$3.05M

Top Sells

1
MITA
Coliseum Acquisition Corp. Class A Ordinary Share
MITA
$4.7M
2
ZGNX
Zogenix, Inc.
ZGNX
$2.19M
3
DNMR
Danimer Scientific, Inc.
DNMR
$1.7M
4
REGN icon
Regeneron Pharmaceuticals
REGN
$1.4M
5
SDIG
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
$1.17M

Sector Composition

1 Healthcare 28.03%
2 Financials 21.93%
3 Materials 19.81%
4 Communication Services 5.75%
5 Real Estate 5.33%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BRIV
26
DELISTED
B. Riley Principal 250 Merger Corp. Class A common stock
BRIV
$3.41M 1.09%
350,000
– –
ABBV icon
27
AbbVie
ABBV
$372B
$3.25M 1.03%
20,037
+10,037
+100% +$1.63M
KAIR
28
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
$3.25M 1.03%
330,963
-14,500
-4% -$142K
EIGR
29
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$3.23M 1.03%
389,292
+71,800
+23% +$596K
BMY icon
30
Bristol-Myers Squibb
BMY
$96B
$3.1M 0.99%
42,409
– –
BIP icon
31
Brookfield Infrastructure Partners
BIP
$14.6B
$2.98M 0.95%
+45,000
New +$2.98M
KKR icon
32
KKR & Co
KKR
$124B
$2.92M 0.93%
50,000
– –
GLHAW
33
DELISTED
Glass Houses Acquisition Corp. Warrant
GLHAW
$2.88M 0.92%
250,000
– –
REGN icon
34
Regeneron Pharmaceuticals
REGN
$61.5B
$2.79M 0.89%
4,000
-2,000
-33% -$1.4M
JPM icon
35
JPMorgan Chase
JPM
$829B
$2.76M 0.88%
20,220
+7,300
+57% +$995K
CTIC
36
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$2.6M 0.83%
556,687
+335,608
+152% +$1.57M
AB icon
37
AllianceBernstein
AB
$4.38B
$2.38M 0.76%
50,500
– –
RHP icon
38
Ryman Hospitality Properties
RHP
$6.22B
$2.26M 0.72%
24,400
+12,000
+97% +$1.11M
INVA icon
39
Innoviva
INVA
$1.29B
$2.23M 0.71%
115,269
– –
BBIO icon
40
BridgeBio Pharma
BBIO
$9.89B
$2.04M 0.65%
+200,893
New +$2.04M
XENE icon
41
Xenon Pharmaceuticals
XENE
$2.98B
$2.03M 0.65%
66,500
-19,988
-23% -$611K
MRK icon
42
Merck
MRK
$210B
$2.01M 0.64%
24,500
+23,200
+1,785% +$1.9M
PMGM
43
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
$1.98M 0.63%
200,000
– –
TWLVW
44
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
$1.92M 0.61%
166,666
-5,000
-3% -$57.5K
SRRA
45
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$1.79M 0.57%
+55,758
New +$1.79M
KAIRW
46
DELISTED
Kairos Acquisition Corp. Warrant
KAIRW
$1.6M 0.51%
139,278
-7,250
-5% -$83.4K
GREE icon
47
Greenidge Generation Holdings
GREE
$19.3M
$1.59M 0.51%
185,060
– –
RDUS
48
DELISTED
Radius Health, Inc.
RDUS
$1.57M 0.5%
+178,218
New +$1.57M
CHRS icon
49
Coherus Oncology, Inc. Common Stock
CHRS
$135M
$1.52M 0.48%
117,555
+15,000
+15% +$194K
AVDL
50
Avadel Pharmaceuticals
AVDL
$1.43B
$1.42M 0.45%
207,663
-50,535
-20% -$345K
1
2
3 4 5